One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles-Reference-Cited by-同舟云学术

One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles

Published:2014-12 Issue:37 Volume:35 Page:9930-9940
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Kao Chien-Han,Wang Jaw-Yuan,Chuang Kuo-Hsiang,Chuang Chih-Hung,Cheng Ta-Chun,Hsieh Yuan-Chin,Tseng Yun-long,Chen Bing-Mae,Roffler Steve R.,Cheng Tian-Lu

Funder

National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan

Ministry of Health and Welfare, Taiwan

103NSYSU-KMU Joint Research Project

Biosignature in Colorectal Cancers

Academia Sinica, Taiwan

Academia Sinica Research Program on Nanoscience and Nanotechnology

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference51 articles.

1. Sterically stabilized liposomes;Woodle;Biochim Biophys Acta,1992

2. Factors affecting the clearance and biodistribution of polymeric nanoparticles;Alexis;Mol Pharm,2008

3. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation;He;Small,2011

4. Covalently PEGylated carbon nanotubes with stealth character in vivo;Yang;Small,2008

5. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy;Gabizon;Cancer Invest,2001

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The advancements and prospective developments in anti-tumor targeted therapy;Neoplasia;2024-10

2. EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer;International Journal of Nanomedicine;2024-04

3. Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.;Journal of Controlled Release;2024-03

4. Targeted internalization and activation of glycosidic switch liposomes by an EphA2 PEG engager increases therapeutic efficacy against lung cancer;2024-02-23

5. Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20);Cancer Nanotechnology;2023-10-06